FDA Inspection
Avesta Pharma Private LimitedAvesta Pharma Private Limited – FDA Inspection, Mar 24, 2023
Record Details
This FDA Inspection record concerns Avesta Pharma Private Limited, with an inspection on March 24, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 306cf62d-82e3-445c-9388-f2adc38e0d80
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1202740
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Avesta Pharma Private Limited
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 22, 2019 | Not classified | Office of Inspections and Investigations |
Other documents for Avesta Pharma Private Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.